Cargando…
Characterization of CADD522, a small molecule that inhibits RUNX2-DNA binding and exhibits antitumor activity
The RUNX2 transcription factor promotes breast cancer growth and metastasis through interactions with a variety of cofactors that activate or repress target genes. Using a direct drug discovery approach we identified CADD522 as a small molecule that inhibits the DNA binding of the runt box domain pr...
Autores principales: | Kim, Myoung Sook, Gernapudi, Ramkishore, Choi, Eun Yong, Lapidus, Rena G., Passaniti, Antonino |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5642608/ https://www.ncbi.nlm.nih.gov/pubmed/29050333 http://dx.doi.org/10.18632/oncotarget.20200 |
Ejemplares similares
-
YBX1-interacting small RNAs and RUNX2 can be blocked in primary bone cancer using CADD522
por: Green, Darrell, et al.
Publicado: (2023) -
Targeting breast cancer metabolism with a novel inhibitor of mitochondrial ATP synthesis
por: Kim, Myoung Sook, et al.
Publicado: (2020) -
COVID-19: CADD to the rescue
por: Onawole, Abdulmujeeb T., et al.
Publicado: (2020) -
CADD, Computer Aided Detector Design
por: Ferran, P M, et al.
Publicado: (1992) -
CADD: Computer Aided Detector Design
por: Ferran, P M
Publicado: (1993)